Czech Cell Therapy Increases Survival in Ovarian Cancer by 62%
The Czech biotech company Sotio has shown in a phase II trial that its cellular…
20/03/2019 - 2 minutes
Immuno-oncology
Can This Mouse Model Help Us Cure Cancer?
The human immune system is highly complex. Not only is it made up of millions…
11/03/2019 - 10 minutes
Taking Immune Monitoring to a Whole New Level
In 2018, there were approximately 3,400 active agents in the immuno-oncology pipeline, a 67% increase…
27/02/2019 - 5 minutes
Immuno-oncology Biotech Raises €31M to Progress T-Cell Boosting Therapy
The Swiss biotech Anaveon closed a very respectable €31M (CHF35M) Series A fundraising round to…
26/02/2019 - 2 minutes
Series A to Fund Therapy That Exposes Cancer to Immune System
The UK biotech Grey Wolf Therapeutics has raised €11.4M (£10M) to fuel the development of…
11/02/2019 - 2 minutes
This Company is Advancing Immuno-Oncology Research with its Full Human Immune System Mouse Models
Research on immunotherapies against cancer dates back over a century ago, when Paul Ehrlich hypothesized…
06/02/2019 - 6 minutes
Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents
Update (01/02/2019): MorphoSys has agreed to end its long-running legal battle with Genmab and Janssen, after…
28/01/2019 - 3 minutes
Personalized Immunotherapy for Brain Cancer Succeeds in Clinical Trials
A European trial has proved the feasibility and efficacy of treating cancer with a personalized…
20/12/2018 - 3 minutes
Mastering the Competitive World of Immuno-oncology
In recent years the oncology world has focused on using the immune system to target…
25/10/2018 - 5 minutes
How To Break Into The Crowded Immuno-Oncology Space
The field of immuno-oncology promises to make anti-cancer treatments more effective than ever. But in…
11/09/2018 - 6 minutes
Affimed Collaborates with Genentech in Cancer Immunotherapy Deal Worth €4.4B
The German biotech will partner with Genentech, part of the Roche Group, to develop targeted…
29/08/2018 - 2 minutes
Update: Gilead and Novartis’s CAR T-Cell Therapies Approved in Europe
Update: Following on from earlier approvals in the US, the European Commission announced it has given…
28/08/2018 - 4 minutes
